The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...

Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management: Beijing, China Monday, December 1, 2025, 18:00 Hrs [IST] Gan ...

Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.

Children with avoidant/restrictive food intake were significantly more likely than control individuals to have developmental ...

A new study highlights how important uninterrupted sleep is to recovery after a traumatic brain injury, finding that ...

A homegrown breast cancer therapy has shown promising efficacy and safety in a clinical trial announced on Wednesday by ...

Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock surged 17.4% in premarket trading Tuesday after the clinical-stage biotech company reported positive preliminary data from its ETESIAN ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt ...

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term ...

Learn more about whether Immunocore Holdings plc or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Alkermes plc or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...